You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
AstraZeneca's new cholesterol pill is showing promise, while the FTC urged a potential buyer of 23andMe to protect user data.
You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.